WELCOME TO THE
JANDA LAB
News from the lab
Our group merges chemical and biological approaches into a cohesive research program. We explore the intersection of chemistry and immunology, with a particular focus on harnessing the power of adaptive immune responses and functional antibody design. Our diverse research interests entail catalytic antibody development, biochemical reactivity of drugs of abuse and immunopharmacotherapy for drug abuse, regulation of body weight and metabolism, detection of and protection from warfare agents, bacterial cell-cell communication, phage display technology, neglected tropical disease diagnostics and therapeutics as well as organic synthesis methods.
The information on the Janda Lab website represents that of the author and not that of Scripps Research. The Janda Lab takes full responsibility for the information presented. Accidental errors will be corrected in a timely manner.
NEW PUBLICATION:
"Redefining Drug Immune Recognition: A Radically Reconfigured Molecular Architecture Enables Broad Fentanyl-Class Protection"
NEW GRANT:
Exciting news — our "PROTAC Strategy to Combat Botulinum Neurotoxicity" project has just been awarded two years of funding from the NIH! Congressman Mike Levin (CA-49) even reached out to congratulate Kim on the achievement. We are very grateful for this support and excited for what's ahead as we advance this research.
